MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Tauopathies"

  • 2026 International Congress

    Sex comparisons for co-pathologies and clinical phenotypes in autopsy-confirmed four-repeat tauopathies

    E. Bayram, D. Carter, S. Aslam, E. Forbes, S. Holden (Aurora, USA)

    Objective: To assess whether co-pathologies and clinical phenotypes in people with four-repeat tauopathies (progressive supranuclear palsy [PSP], corticobasal degeneration [CBD]) differ by sex. Background: PSP…
  • 2026 International Congress

    TMEM106B Amyloid Fibrils in the Choroid Plexus Mediate [18F]AV-1451 Retention: Cohort-Level Imaging and Cryo-EM Evidence

    Y. Fan, WB. Zhao, QY. Zhao, JY. Lu, D. Li, J. Wang (Shanghai, China)

    Objective: To determine whether TMEM106B fibrils contribute to AV-1451 retention in the choroid plexus (CP) and to elucidate the structural basis of their binding. Background:…
  • 2026 International Congress

    GBA1 deficiency promotes tau and TDP-43 co-pathology

    A. Park, L. Lee, M. Kim, M. Callier, E. Chiu, C. Latimer, M. Davis (Seattle, USA)

    Objective: To determine whether mutations in the gene beta-glucocerebrosidase 1 (GBA1), the strongest genetic risk factor for PD, promote tau and TDP-43 co-pathology alongside Lewy…
  • 2026 International Congress

    Emerging Roles for Imaging Techniques in Differentiating Underlying Pathologies in Corticobasal Syndrome

    P. Bhaya, D. Petrosyan, N. Nguyen, L. Saadatpour, E. Vaou, S. Horn, P. Coss (San Antonio, USA)

    Objective: This review evaluates limitations in differentiating underlying pathologies in Corticobasal syndrome (CBS). We summarize available evidence on clinical features, imaging and fluid biomarkers and…
  • 2026 International Congress

    Paired cerebrospinal fluid and serum analysis of irisin and associated LC3B levels in Parkinson’s disease and atypical Parkinsonism

    S. Witte, C. van Riesen, M. Bähr, F. Maass (Göttingen, Germany)

    Objective: The objective of the study is to investigate potential group differences in irisin and LC3B levels in paired cerebrospinal fluid (CSF) and serum samples…
  • 2026 International Congress

    An Elevation in the Serum Biomarker pTau-181 May Identify Progressive Supranuclear Palsy Pathology

    K. Ramirez (Redwood City, USA)

    Objective: To report three cases of progressive supranuclear palsy (PSP) with significantly elevated pTau-181 levels on serum testing. Background: According to the MDS-endorsed PSP Study…
  • 2026 International Congress

    Identification of Alpha-synuclein Pathology in Primary Tauopathies by Seed Amplification Assay

    C. Farris, S. Weber, Y. Ma, M. Starke, D. Irwin, A. Siderowf, B. Mollenhauer, L. Concha (San Diego, USA)

    Objective: To assess intravitam frequency and type of misfolded α-synuclein aggregates (syn-seeds) in participants with clinically defined primary tauopathies, such as progressive supranuclear palsy (PSP)…
  • 2026 International Congress

    Exploring the Genetic Landscape of Corticobasal Syndrome in Asian Populations

    CY. Liu, PS. Chen, MZ. Hung, NC. Lee, SP. Fan, CH. Lee, CH. Tai, HL. Chiang, CY. Chen, YR. Wu, YY. Chang, CS. Lu, T. Nomura, H. Yaguchi, TS. Toh, AH. Tan, EK. Tan, I. Yabe, SY. Lim, CH. Lin (Taipei, Taiwan)

    Objective: We aimed to investigate the genetic spectrum of corticobasal syndrome (CBS) in a sizable Asian cohort. Background: CBS is a rare, rapidly progressive neurodegenerative…
  • 2026 International Congress

    Plasma Phospho-Tau217 and Neuromelanin-Sensitive MRI as Candidate Biomarkers in Beta-Propeller Protein-Associated Neurodegeneration

    JH. Lee, YS. Kim (Yangsan, Republic of Korea)

    Objective: To evaluate plasma phosphorylated tau at threonine 217 (pTau217) and neuromelanin-sensitive MRI (NM-MRI) as candidate biomarkers reflecting tau pathology and nigral iron deposition in…
  • 2025 International Congress

    Disease Characteristics of the First 100 Participants in the CurePSP Genetics Program Cohort

    C. Obasi, V. Zhao, C. Martinez, S. Scholz, H. Morris, N. Mcfarland, M. Nance, J. Wang, N. Mencacci, B. Cuoto, T. Foroud, J. Verbrugge, A. Miller, L. Heathers, L. Honig, A. Lang, F. Rodriguez-Porcel, P. Moretti, M. Mesaros, J. Brummet, K. Diaz, A. Wills (Boston, USA)

    Objective: To increase our understanding of the pathogenesis of atypical parkinsonian disorders though genetics, and to build a cohort of individuals for future research. Background:…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 16
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley